1. Home
  2. CTBI vs PHAR Comparison

CTBI vs PHAR Comparison

Compare CTBI & PHAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTBI
  • PHAR
  • Stock Information
  • Founded
  • CTBI 1903
  • PHAR 1988
  • Country
  • CTBI United States
  • PHAR Netherlands
  • Employees
  • CTBI N/A
  • PHAR N/A
  • Industry
  • CTBI Major Banks
  • PHAR Biotechnology: Pharmaceutical Preparations
  • Sector
  • CTBI Finance
  • PHAR Health Care
  • Exchange
  • CTBI Nasdaq
  • PHAR Nasdaq
  • Market Cap
  • CTBI 1.0B
  • PHAR 951.7M
  • IPO Year
  • CTBI N/A
  • PHAR N/A
  • Fundamental
  • Price
  • CTBI $55.55
  • PHAR $14.55
  • Analyst Decision
  • CTBI Buy
  • PHAR Strong Buy
  • Analyst Count
  • CTBI 3
  • PHAR 3
  • Target Price
  • CTBI $59.00
  • PHAR $30.00
  • AVG Volume (30 Days)
  • CTBI 61.8K
  • PHAR 14.4K
  • Earning Date
  • CTBI 10-17-2025
  • PHAR 10-23-2025
  • Dividend Yield
  • CTBI 3.81%
  • PHAR N/A
  • EPS Growth
  • CTBI 17.47
  • PHAR N/A
  • EPS
  • CTBI 5.08
  • PHAR N/A
  • Revenue
  • CTBI $253,839,000.00
  • PHAR $339,836,000.00
  • Revenue This Year
  • CTBI $20.43
  • PHAR $17.44
  • Revenue Next Year
  • CTBI $4.40
  • PHAR $8.46
  • P/E Ratio
  • CTBI $10.96
  • PHAR N/A
  • Revenue Growth
  • CTBI 12.25
  • PHAR 22.44
  • 52 Week Low
  • CTBI $44.60
  • PHAR $7.31
  • 52 Week High
  • CTBI $61.67
  • PHAR $17.08
  • Technical
  • Relative Strength Index (RSI)
  • CTBI 45.10
  • PHAR 51.90
  • Support Level
  • CTBI $54.50
  • PHAR $13.18
  • Resistance Level
  • CTBI $56.53
  • PHAR $16.29
  • Average True Range (ATR)
  • CTBI 0.93
  • PHAR 0.55
  • MACD
  • CTBI -0.09
  • PHAR -0.04
  • Stochastic Oscillator
  • CTBI 30.00
  • PHAR 44.05

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

About PHAR Pharming Group N.V.

Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.

Share on Social Networks: